RCUS
Arcus Biosciences Inc
25.20$
-1.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +73.6% | +44.3% | -26.1% | +280.2% | +106.1% | -15.5% | -18.6% | +5.0% | -1.0% | |
| – | +77.4% | +46.4% | -25.6% | +281.8% | +71.5% | -15.5% | -22.0% | +22.3% | -0.9% | |
| – | +51.1% | -27.8% | -18.5% | +199.3% | -14.7% | +39.3% | -38.3% | +18.1% | +48.0% | |
| – | +77.7% | +46.0% | -26.6% | +287.0% | -31.5% | +102.1% | -24.8% | +28.9% | +0.3% | |
| – | -93.8% | +232.0% | +59.0% | +1,186.4% | +43,882.4% | -94.2% | -2.3% | -40.5% | -36.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +30.5% | -1.1% | -16.0% | +15.8% | +200.3% | +316.0% | – | – | – | |
| – | +257.5% | +9.2% | -1.8% | +587.6% | +178.0% | -8.3% | -8.0% | +5.1% | -23.6% | |
| – | +129.5% | +33.1% | +34.1% | +435.8% | +36.5% | +16.2% | -4.7% | +22.8% | +2.2% | |
| – | – | +92.0% | +58.1% | -69.9% | +77.9% | -41.2% | +266.7% | +9.1% | +8.3% | |
| – | -1.2% | -18.8% | +51.6% | +233.4% | -34.6% | +94.9% | -15.0% | +5.9% | +133.3% | |
| – | – | – | – | – | – | – | – | – | +106.3% | |
| – | +54.7% | +52.7% | -30.3% | +206.6% | +67.5% | -21.9% | -29.7% | +5.0% | +30.1% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +41.0% | +26.6% | +25.0% | +35.0% | -2.7% | +2.8% | +21.8% | +19.2% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.